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ABSTRACT
Background: The experimental porcine model is anatomically 
and physiologically similar to the human heart; it is easily 
reproducible and very useful to test new stent and balloon 
generations. This study was aimed at analyzing an experimental 
model to evaluate different coronary devices for percutaneous 
coronary intervention. Methods: We evaluated 131 juvenile 
commercial farm pigs, 109 were female, weighing 26.4 ± 
3.2 kg. They were anesthetized and had mechanical ventilation 
and monitoring. Vascular access was obtained via the femoral 
artery by dissection or puncture. The coronary device was used 
after a selective catheterization of the coronary arteries with 
a JR 6 F catheter. Animals were maintained on mechanical 
ventilation until recovery and were submitted to angiographic 
evaluation 7, 28, 90 and/or 180 days after the procedure. After 
euthanasia, the hearts were collected and submitted to macro 
and microscopic analysis. Results: Six drug-eluting stents, two 
drug-eluting balloons and two bare-metal stents were tested. 
Unplanned deaths were observed in 1.5% of the cases during 
the procedures and in 9.2% of the cases after the procedure, 
occurring within 12 hours to 6 days (2.3 ± 1.6 days). In ad-
dition to angiographic evaluations, intravascular ultrasound 
and optical coherence tomography were performed during the 
procedures in 20% and 60% of the cases, respectively. There 
was no death related to the use of the devices. Conclusions: 
The experimental percutaneous porcine model proved to be 
reproducible with similar outcomes and low mortality for the 
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RESUMO
Modelo Porcino para Avaliação e Desenvolvimento 
de Diferentes Dispositivos Coronários Baseados em 
Cateter: Ferramenta Pré-Clínica Fundamental
Introdução: O modelo experimental porcino tem grande simi-
laridade anatômica e fisiológica com o coração humano, e é 
de fácil reprodutibilidade, sendo de grande valia para testar 
novas gerações de stents e balões. Este estudo teve como 
objetivo analisar o desempenho de um modelo experimen-
tal para intervenção coronária percutânea na avaliação de 
diferentes dispositivos coronários. Métodos: Foram estudados 
131 porcos juvenis de granja comercial, sendo 109 fêmeas, 
pesando 26,4 ± 3,2 kg, anestesiados, monitorados e venti-
lados mecanicamente, com acesso vascular obtido por via 
femoral (dissecção ou punção). Após a cateterização seletiva 
das artérias coronárias com cateter JR 6 F, procedeu-se à 
utilização do dispositivo coronário a ser estudado. Os animais 
foram mantidos sob ventilação mecânica até a recuperação e 
submetidos a reestudos angiográficos 7, 28, 90 e/ou 180 dias 
após o procedimento. Após a eutanásia, os corações foram 
coletados e submetidos a análises macro e microscópicas. 
Resultados: Foram testados seis stents farmacológicos, dois 
balões farmacológicos e dois stents não farmacológico. O óbito 
intraprocedimento não planejado incidiu em 1,5% dos casos e, 
no pós-procedimento, em 9,2%, ocorrendo em um período de 
12 horas a 6 dias (2,3 ± 1,6 dias). Além das análises obtidas 
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different devices tested and is an essential tool for the evalu-
ation of new coronary devices.
 
 
 
 
 
DESCRIPTORS: Models, animal. Percutaneous coronary inter-
vention. Drug-eluting stents.
T he experimental porcine model is extremely use-ful to test new generations of stents and balloons, and is the most used model in the evaluation of 
coronary devices. The main advantages of this animal 
model are its anatomical and physiological similarities 
with human hearts.1 The distribution of the coronary 
arteries, myocardial supply by collaterals, the coagu-
lation system, and platelet activity are very similar to 
those found in humans.2-4 
Although in the healing response to vascular injury 
involves similar processes and phases, the time course 
of events in pigs is different from humans. Based on 
the periods of restenosis development after implantation 
of drug-eluting stents, a time ratio of 1 to 6 (animal to 
human) is usually observed.5-9
Although animal production is not expensive, the 
costs of handling and housing are high. In Brazil, invest-
ments in the public and private sectors of translational 
research are justified when the ultimate goal is the 
application of improved technologies, many of which 
are developed in the country, which should translate 
into benefits for patients with cardiovascular disease.
To participate in research, development, and innovation 
activities in the field of percutaneous coronary interven-
tion, the subject of intense interest in many countries in 
the world, it is necessary to have well-established and 
reproducible animal models – as this has been a mandatory 
step in the effectiveness assessment of any new coronary 
device, as required by the United States (Food and Drug 
Administration [FDA]) and European (European Medicines 
Agency [EMEA]) regulatory agencies.10,11 
This study aimed to analyze the performance of an 
experimental model for percutaneous coronary interven-
tion in the evaluation of different coronary devices.
METHODS
All experiments were performed according to the 
protocol approved by the Institutional Research Ethics 
Committee. In this study, domestic pigs (Sus scrofa 
domestica, MS60, EMBRAPA) were used. All animals 
underwent clinical examination before the start of 
protocol, and only those with no signs of disease were 
used in the study.
pela angiografia, foram realizados, durante os procedimentos, 
ultrassom intracoronário em 20% e tomografia de coerência 
óptica em 60%, não sendo observados óbitos relacionados 
ao emprego dessas ferramentas. Conclusões: O modelo ex-
perimental porcino percutâneo mostrou ser reprodutível, com 
desempenho homogêneo entre os vários dispositivos e de baixa 
mortalidade, sendo ferramenta indispensável na investigação 
de novos dispositivos coronários.
DESCRITORES: Modelos animais. Intervenção coronária per-
cutânea. Stents farmacológicos.
The animals were kept in a local commercial farm, 
with free access to water and food during the protocols. 
They were acclimated in the Experimental Division of 
Instituto do Coração, Hospital das Clínicas, University 
of São Paulo (Incor-FMUSP), Brazil, for at least 24 hours 
before catheterization.
Anesthesia procedure
The animals were sedated before the procedure 
with a mixture of ketamine chloride (8 mg/kg) and 
midazolam chloride (0.5 mg/kg). After 10 to 20 minutes, 
an IV line was inserted (superficial ear vein). Anesthesia 
was induced with thiopental sodium (12.5 mg/kg) and 
then orotracheal intubation was performed with a long 
straight blade laryngoscope (7 or 7.5-mm tube). Anes-
thesia was maintained with 1.5% to 2.5% isoflurane 
and 100% oxygen in the anesthetic equipment. Before 
the procedure, the pigs received an intramuscular in-
jection of benzathine penicillin (1.2 million units), to 
prevent infections.
Platelet antiaggregants were started 24 hours before 
the procedure: 300 to 600 mg of acetylsalicylic acid 
(ASA) and 75 to 150 mg of clopidogrel. The maintenance 
dose was 100 mg and 75 mg for ASA and clopidogrel, 
respectively.
Cardiac catheterization and invasive and 
noninvasive monitoring
The pigs were placed in the supine position under 
general anesthesia. Oxygen saturation was monitored 
through the tail of the animal, and the heart rate and 
rhythm by a heart monitor. After inguinal asepsis, a 6F 
vascular sheath was introduced by direct visualization 
into the common femoral artery through puncture or 
dissection, followed by the administration of 10,000 
units of heparin, while maintaining invasive blood 
pressure monitoring.
The right and left coronary arteries were selectively 
cannulated using a therapeutic 6F Judkins catheter (Philips, 
Eindhoven, the Netherlands) monitored by fluoroscopy 
provided by digital angiography Philips BV Pulsera (Philips, 
Eindhoven, the Netherlands) equipment. Intracoronary injec-
tion of nitroglycerin at a dose of 200 mg and subsequent 
injection of iodinated contrast for the acquisition of the 
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initial angiography was administered. The angiographic 
projection of choice for both the left and right coronary 
arteries was the left anterior oblique 60° projection. 
In case of acute ventricular arrhythmia, bolus 
doses of lidocaine hydrochloride (2.5 to 12 mg/kg) 
were administered. When ventricular fibrillation was 
detected, electrical cardioversion was performed by 
applying 200 to 300 J, with the paddles placed against 
the anterior chest wall.
Tested devices, restudy, and euthanasia
The devices tested were drug-eluting balloons, drug-
eluting stents, and bare-metal stents. The angiographic 
study was performed at seven, 28, 90, and 180 days, 
depending on the current protocol. 
The animals, under deep anesthesia, were euthanized 
with a lethal dose of potassium chloride. A left parame-
dian thoracotomy was performed and the pericardium 
was opened. The vena cava, pulmonary artery, and aorta 
were carefully clamped and severed, and then the heart 
was removed. Then, the hearts were washed with clean 
water and a solution of 10% formalin was infused under 
pressure of 100 mmHg at the aortic root, for coronary 
perfusion for 30 minutes. The arterial segment containing 
the stent was dissected, removed, and placed in a solution 
of 10% formalin, and submitted to histological processing.
Use of adjunct intravascular imaging methods 
Prior to the methods of intravascular imaging, in-
tracoronary nitrate (10-20 mg of isosorbide mononitrate, 
or 150 to 400 μg of nitroglycerin) was administered to 
promote epicardial vasodilation and prevent arterial spasm.
The intravascular ultrasound (IVUS) was performed 
using an Atlantis 40 MHz catheter connected to an 
iLab console (both from Boston Scientific Inc., United 
States). The acquisition was performed during automatic 
retreat of 0.5 mm/s.
At the optical coherence tomography (OCT), an 
OCT M2 system (LightLab Imaging, Westford, United 
States) was used with automated retreat of the Im-
ageWireTM image catheter (LightLab Imaging, Westford, 
United States) at the rate of 1 to 2 mm/s, after previous 
proximal occlusion of the coronary artery with Helios® 
balloon (LightLab Imaging) and saline solution infusion.
Scanning electron microscopy
The coronary artery segment containing the stent 
was dissected, removed, and subjected to a longitudinal 
section, with one half sent to pathology and the other 
half to specific processing and further analysis in a 
scanning electron microscope.
The hemi-segment containing the stent was im-
mersed in modified Karnovsky solution for 12 hours at 
4°C, washed in buffer solution of sodium cacodylate, 
post-fixed in a 1% buffered osmium tetroxide solution, 
and dehydrated in an increasing series of alcohol solu-
tions, up to absolute alcohol. The drying of the samples 
was performed to the critical point in a Balzers CPD 
030 apparatus.
The samples were metallized with gold ions in a Balz-
ers SCD 040 apparatus and analyzed with a JSM 7401S 
scanning electron microscope (JEOL – Japan), which takes 
pictures with a magnification of 25×. The images were 
stored and submitted to analysis using Adobe® Photoshop® 
software, version 7.0 (Adobe Systems Inc.) and ImageJ 
version 1.42q for Windows (NIH – Bethesda, United 
States), and areas of the exposed stent struts (mm2) were 
measured and the percentages of endothelization for each 
stent type were calculated (Figure 1).
Figure 1 – Scanning electron microscopy of porcine coronary artery seven days after drug-eluting stent implantation, showing the bare struts. In the 
detail, the strut showing polymer coating delamination, magnified to the right.
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Histopathological analysis
The sections were stained with hematoxylin-eosin 
and Verhoeff staining for elastic fibers and subsequently 
analyzed qualitatively and quantitatively by patholo-
gists and a specialized technician. At the quantitative 
analysis, the modified Kornovski et al. inflammation 
scores,12 the fibrin score,13 and the Schwartz injury 
scores were used.10,14
Quantitation of the area of the lumen, stent, in-
ternal elastic lamina, external elastic lamina area, and 
neointimal thickness on the struts and inter-strut was 
performed using Leica Qwin software (Leica Microsys-
tems, Wetzlan, Germany).
RESULTS
A total of 131 juvenile pigs obtained from a 
commercial farm were studied from 2006 to 2012, of 
which 109 were female, weighing 26.4 ± 3.2 kg. The 
animals were maintained on mechanical ventilation 
until recovery and submitted to restudy after seven, 
28, 90, and 180 days.
Six drug-eluting stents, two drug-eluting balloons, and 
two bare-metal stents (Table 1) were tested. Unplanned 
intra-procedural death was 1.5%, and post-procedure 
death was 9.2%, occurring from 12 hours up to six days 
(2.3 ± 1.6 days). In addition to the analysis obtained 
by angiography, IVUS and OCT were performed in 
20% and 60% of the animals during procedures, re-
spectively, with no deaths observed during the use of 
these tools (Figure 2).
DISCUSSION
The present study reflects the results of a pioneering 
center for pre-clinical validation in Brazil, specifically 
organized and equipped for the scientific evaluation 
of devices and procedures for percutaneous coronary 
intervention. The knowledge gained from the porcine 
model over the years, among other devices, has allowed 
the authors to participate in the development of the first 
stent of Brazilian design, using technological innovations 
in its creation.15-19 These results were obtained thanks 
to the implementation of several complex processes, 
which began with the design of a new endovascular 
device and continued through the steps of producing 
prototypes, validation of preclinical tests, (mechanical 
and biological in vitro and in vivo) and, finally, tests 
of safety and efficacy in humans.20
The histopathological analysis is part of this process, 
which remains the current standard for evaluation of 
devices to be studied. Such histological processing of 
vessels with stents is one of the most limiting factors in 
the process, due to the risk of damage to tissues adjacent 
to stent struts. The inclusion in methacrylate resin and 
Table 1
Description of coronary devices studied using the porcine model
Studied devices Date n
Nitric oxide-eluting stent April 2006 9
National cobalt-chromium stent August 2006 10
Supralimus vs. sirolimus stent March 2007 3
Pre-assembled national cobalt-chromium stent September 2007 3
Bare-metal stents of different models July 2008 5
National sirolimus-eluting stent October 2008 6
National drug-eluting stent with external vs. internal and external drug coating May 2009 14
Sirolimus vs. paclitaxel-eluting stents December 2009 7
Nitric oxide-eluting stent March 2010 4
Sirolimus-eluting stent June 2010 16
Everolimus vs. sirolimus-eluting stent August 2010 14
National cobalt-chromium stent vs. national sirolimus-eluting stent 180 days September 2010 4
Comparison of stents with clot vs. thrombus November 2010 4
National cobalt-chromium stent vs. sirolimus-eluting stent in overlapping December 2010 3
National cobalt-chromium stent vs. national sirolimus-eluting stent 90 days December 2010 7
Nanomagnetic stent June 2011 4
Sirolimus-eluting stent September 2011 10
National stent with new design September 2012 8
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micrometric sectioning of specimens containing metal 
are the main difficulties that restrict the histological 
processing of stents to a few centers worldwide.
Currently, it is recommended that these models, 
previously used as benchmark tests to evaluate the 
effectiveness of new devices, should focus specifically 
on the safety aspects.21 For that purpose, the stent per-
formance should be evaluated sequentially. Therefore, it 
is essential to have intravascular imaging methods that 
allow the outcome assessment at different moments of 
the vascular healing process.
IVUS, despite providing a volumetric estimate of 
all the neointimal tissue, has little precise correlation 
with histological findings.22,23 Therefore, this is not 
the best technique to assess the presence of fibrin or 
thrombus, nor does it have enough spatial resolution to 
verify whether the stent struts are coated or denuded.
OCT, on the contrary, showed a high correlation 
with histological findings24,25 due to its high axial 
resolution, allowing for a proper categorization of the 
stent struts as denuded or coated.25,26 Heterogeneous 
images with low light intensity signal, visible at OCT, 
correlated with areas of low cellularity, with presence 
of fibrin and proteoglycans.19,27,28 
Currently, the evaluation at 28 days is recommended 
to verify the occurrence of neointimal hyperplasia, and 
at least once more, to analyze the long-term effects. The 
second evaluation (after three to six months) depends 
on the time when the healing of the treated segment 
and drug release were completed. It is noteworthy 
that, for drug-eluting stents, the FDA recommended 
a six-month interval after stent implantation to obtain 
preclinical data; more recently, it has extended this 
recommendation to one year after implantation.10,11
CONCLUSIONS
The percutaneous porcine experimental model 
showed to be reproducible, with homogeneous behavior 
among the different tested devices and low mortality, 
representing an indispensable tool in the investigation 
of new coronary devices.
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Figure 2 – Cross-sections of porcine coronary artery with drug-eluting stent. (A) Optical coherence tomography; (B) Histological analysis; (C) overlap-
ping images, aiming to choose the cross-section of optical coherence tomography analogous to the histological picture. 
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